Results for tag: "Mucosal Vaccine"

The Mucosal Vaccine market is a subset of the Vaccines market, focusing on vaccines that are administered through mucosal surfaces such as the nose, mouth, and rectum. These vaccines are designed to induce an immune response at the site of administration, as well as in the systemic circulation. Mucosal vaccines are used to prevent a variety of infectious diseases, including influenza, rotavirus, and cholera. They are also used to protect against allergies and autoimmune diseases. Mucosal vaccines are typically administered as a nasal spray, oral drops, or rectal suppositories. They are often combined with adjuvants, which are substances that enhance the immune response to the vaccine. Adjuvants can include aluminum salts, liposomes, and polysaccharides. Some companies in the Mucosal Vaccine market include GlaxoSmithKline, Merck, Pfizer, Sanofi, and Novavax. Show Less Read more